Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi
Open Access
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 98 (5) , 405-410
Abstract
No abstract availableKeywords
Funding Information
- U.S. Agency for International Development (AID-OAA-A-12-00047)
- Children's Investment Fund Foundation
This publication has 9 references indexed in Scilit:
- Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trialContraception, 2018
- Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trialThe Lancet Global Health, 2018
- Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort studyContraception, 2017
- Acceptability of the community-level provision of Sayana® Press by medical and nursing students in Kinshasa, Democratic Republic of the CongoContraception, 2017
- A prospective cohort study of the feasibility and acceptability of depot medroxyprogesterone acetate administered subcutaneously through self-injectionContraception, 2017
- Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and SenegalContraception, 2014
- Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and SenegalContraception, 2014
- Perceptions of home and self-injection of Sayana® Press in Ethiopia: a qualitative studyContraception, 2014
- How Many Interviews Are Enough?Field Methods, 2006